LFST LifeStance Health Group, Inc. Common Stock
XNAS
13.06
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $4.77 – $14.14
- YTD
- +87.64%
- IV Rank (30D)
- 37.69
- Straddle Price
- $1.58
- P/C Vol Ratio
- 1.63
- Market Cap
- $4.9B
- Open
- $12.93
- Day Range
- $12.82 – $13.20
- Volume
- 3,524,588
- Prev Close
- $12.93
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.13% |
| Beta vs SPY | 1.14 |
| Cost of Equity (CAPM) | 11.38% (VRP-adj) |
| WACC | 11.09% |
| Volatility Risk Premium | +52.6pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 24.5% |
| Rev. Growth (YoY, DCF input) | +19.7% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | 3.4% |
| Book / Price | 29.2% |
| Gross Margin (TTM) | 33.6% |
| FCF Margin (TTM) | 11.0% |
| Debt / Equity | 0.18 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +18.7% (reverse-DCF on current price) |
| SMA 50 | $12.41 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $12.18 |
| Bollinger Width / SMA20 | 82.0% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $5B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $13.64 | 43% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $14.87 | 10% | median 104.0× · 5 peers |
| Peer EV/EBITDA | $7.01 | 13% | median 19.1× · 4 peers |
| Peer P/B | $12.65 | 17% | median 3.3× · 6 peers |
| Peer P/S | $6.63 | 17% | median 1.5× · 6 peers |
| Market Anchor (SMA50) | $12.41 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $13.87 | 0% | 7 strikes · skew -0.51 |
- Industry (SIC)
- SERVICES-HEALTH SERVICES (8000) · industry map
- Exchange
- XNAS
- Market Cap
- $4.9B
- Employees
- 8,542
- List Date
- 2021-06-10
- CIK
- 0001845257
- Next Earnings
- 2026-11-05 (Pre-Market)
- EPS Forecast
- $0.03 (3 est.)
- Headquarters
- Scottsdale, AZ
- Homepage
- https://www.lifestance.com
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -23.70% | 13.55% | -24.30% | 5.56% | 1.58% | -5.46% |
| Feb | -- | 23.11% | -5.01% | 48.05% | -3.11% | 0.84% | 12.78% |
| Mar | -- | 9.30% | 55.11% | -20.75% | -15.80% | -10.78% | 3.42% |
| Apr | -- | -33.30% | 8.81% | -0.32% | -0.90% | 18.84% | -1.37% |
| May | -- | 7.81% | -0.12% | -13.64% | -8.90% | 2.39% | -2.49% |
| Jun | 27.21% | -18.83% | 9.74% | -10.89% | -12.07% | 34.89% | 5.01% |
| Jul | -14.22% | 8.56% | 5.03% | 10.20% | -20.24% | -8.15% | -3.14% |
| Aug | -38.72% | 1.13% | -12.38% | 12.48% | 44.59% | 17.27% | 4.06% |
| Sep | -3.20% | 0.00% | -13.04% | 7.86% | -2.31% | -4.52% | -2.53% |
| Oct | -14.98% | 6.79% | -11.26% | -2.61% | -10.09% | 9.66%* | -3.75% |
| Nov | -38.16% | -33.81% | 20.53% | 10.43% | 32.11% | -- | -1.78% |
| Dec | 20.51% | -10.99% | 19.54% | -1.86% | 9.83% | -- | 7.41% |
| Total | -58.99% | -58.61% | 104.16% | -3.86% | 0.47% | 69.17% | 8.73% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Click Frenzy-Pro™ for an AI analysis of this ticker.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-11 | After-Close | 8.92% | 46.46% | 5.21x | Exceeded |
| 2021-11-08 | After-Close | 22.60% | 24.16% | 1.07x | Exceeded |
| 2022-03-10 | After-Close | 16.50% | 5.12% | 0.31x | Within |
| 2022-05-09 | After-Close | 31.45% | 6.13% | 0.19x | Within |
| 2022-11-08 | After-Close | 10.34% | 28.91% | 2.80x | Exceeded |
| 2023-03-08 | After-Close | 19.46% | 3.39% | 0.17x | Within |
| 2023-05-10 | After-Close | 12.11% | 0.24% | 0.02x | Within |
| 2023-08-09 | After-Close | 9.68% | 2.36% | 0.24x | Within |
| 2023-11-08 | After-Close | 7.73% | 3.44% | 0.45x | Within |
| 2024-02-02 | After-Close | 16.31% | 5.16% | 0.32x | Within |
| 2024-05-09 | After-Close | 13.06% | 3.65% | 0.28x | Within |
| 2024-08-08 | After-Close | 13.49% | 5.56% | 0.41x | Within |
| 2024-11-07 | Pre-Market | 9.12% | 7.71% | 0.85x | Within |
| 2025-02-27 | Pre-Market | 11.65% | 3.06% | 0.26x | Within |
| 2025-05-07 | After-Close | 16.79% | 5.44% | 0.32x | Within |
| 2025-08-07 | Pre-Market | 15.38% | 1.03% | 0.07x | Within |
| 2025-11-06 | Pre-Market | 17.15% | 29.94% | 1.75x | Exceeded |
| 2026-02-25 | After-Close | 15.52% | 6.07% | 0.39x | Within |
| 2026-05-07 | After-Close | 8.76% | 12.99% | 1.48x | Exceeded |
| 2026-08-06 | After-Close | 11.02% | 1.69% | 0.15x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
LFST Options Activity & IV Rank
LFST IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 80th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $38.6M | #741 of 3716 | +89.9% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $10.3M | #1044 of 3138 | +19.9% | 13F | |
| Citadel Hedge fund Ken Griffin | $5.5M | #2017 of 6285 | -86.6% | 13F | |
| Point72 Hedge fund Steve Cohen | $703K | #1569 of 1945 | -91.2% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $33K | #3551 of 4729 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
LFST Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | PEAK6 LLC | $4.28M | 41.91% | 2026-06-30 |
| 2 | Wolverine Trading, LLC Custodian | $2.07M | 20.22% | 2025-09-30 |
| 3 | Susquehanna International Group, LLP Custodian | $1.94M | 19.01% | 2026-06-30 |
| 4 | SYMMETRY PEAK MANAGEMENT LLC | $535.50K | 5.24% | 2026-06-30 |
| 5 | Caption Management, LLC | $382.35K | 3.74% | 2026-06-30 |
| 6 | IMC-Chicago, LLC Custodian | $274.18K | 2.68% | 2026-06-30 |
| 7 | Citadel Advisors LLC Custodian | $266.68K | 2.61% | 2026-06-30 |
| 8 | GROUP ONE TRADING LLC Custodian | $199.21K | 1.95% | 2026-06-30 |
| 9 | Jane Street Group, LLC Custodian | $177.79K | 1.74% | 2026-06-30 |
| 10 | Simplex Trading, LLC Custodian | $70.69K | 0.69% | 2026-06-30 |
| 11 | HAP TRADING, LLC | $22.54K | 0.22% | 2025-09-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Caption Management, LLC | $428.40K | 64.10% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $229.19K | 34.29% | 2026-06-30 |
| 3 | Simplex Trading, LLC Custodian | $10.71K | 1.60% | 2026-06-30 |
LFST Insider Trading (Form 4)
Latest: 2026-09-24| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | David Bourdon | Chief Executive Officer | Gift (G) | — | — | EDGAR | |
| 2026-09-15 | TPG GP A, LLC | 10%+ Owner | Sell (S) | −55,229,115 | $12.29 | -$678.77M | EDGAR |
| 2026-09-04 | David Bourdon | Chief Executive Officer | Other (J) | −150,000 | — | EDGAR | |
| 2026-09-04 | Vukasin Paunovich | Chief Technology Officer | Sell (S) | −42,067 | $12.87 | -$541.4K | EDGAR |
| 2026-08-26 | Ann Varanakis | Chief People Officer | Tax (F) | −8,156 | $12.16 | -$99.2K | EDGAR |
| 2026-08-18 | Teresa DeLuca | Director | Sell (S) | −7,500 | $12.68 | -$95.1K | EDGAR |
| 2026-08-14 | Teresa DeLuca | Director | Sell (S) | −20,441 | $12.23 | -$250.0K | EDGAR |
| 2026-08-13 | Kenneth A Burdick | Director | Sell (S) | −500,000 | $11.51 | -$5.75M | EDGAR |
| 2026-08-12 | Lisa K Miller | Chief Operating Officer | Sell (S) | −47,912 | $10.85 | -$519.8K | EDGAR |
| 2026-08-12 | Vukasin Paunovich | Chief Technology Officer | Sell (S) | −44,394 | $10.85 | -$481.7K | EDGAR |
| 2026-08-12 | James G Coulter | 10%+ Owner | Sell (S) | −40,929,621 | $10.62 | -$434.67M | EDGAR |
| 2026-07-14 | Kenneth A Burdick | Director | Award (A) | +45,495 | — | EDGAR | |
| 2026-07-07 | Sarah Personette | Director | Award (A) | +17,746 | — | EDGAR | |
| 2026-07-07 | Teresa DeLuca | Director | Award (A) | +17,746 | — | EDGAR | |
| 2026-07-07 | Thurman Justice | Director | Award (A) | +35,492 | — | EDGAR |
LFST Insider Holdings
23 insiders · @ $13.06| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jon Winkelried | 10%+ Owner | 140,026,557 | $1.83B | -$435.01M | 1 | 2026-03-04 |
| 2 | James G Coulter | 10%+ Owner | 98,101,407 | $1.28B | -$1.34B | 3 | 2026-08-12 |
| 3 | TPG GP A, LLC | 10%+ Owner | 79,691,702 | $1.04B | -$1.02B | 2 | 2026-09-15 |
| 4 | SUMMIT INVESTORS GE IX/VC IV, LLC | 33,524,715 | $437.83M | -$255.76M | 1 | 2025-08-20 | |
| 5 | Darren M. Black | Director | 23,310,115 | $304.43M | -$185.27M | 6 | 2026-05-14 |
| 6 | Silversmith Partners I GP, LLC | 10%+ Owner | 14,324,197 | $187.07M | -$182.26M | 3 | 2025-08-20 |
| 7 | Ryan Pardo | See Remarks | 3,644,886 | $47.60M | -$1.44M | 15 | 2026-04-03 |
| 8 | Kenneth A Burdick | Director | 3,017,321 | $39.41M | -$6.60M | 11 | 2026-08-13 |
| 9 | Pablo Pantaleoni | Chief Digital Officer | 1,437,881 | $18.78M | -$666.1K | 11 | 2025-05-19 |
| 10 | David Bourdon | Chief Executive Officer | 1,248,247 | $16.30M | -$407.7K | 9 | 2026-09-24 |
LFST Board & Officers
As of SEC filings through Sep 24, 2026Directors 13
- Darren M. Black · since Jun 10, 2021
- Eric Shuey · since Jun 10, 2021
- Katherine Wood · since Jun 10, 2021
- Robert Bessler · since Jun 10, 2021
- Kenneth A Burdick · since Sep 7, 2022
- Teresa DeLuca · since Mar 12, 2024
- David Bourdon · listed since Mar 2025
- Eric P Palmer · since Jun 3, 2025
- Sarah Personette · since Aug 20, 2025
- Ryan Pardo · listed since Mar 2026
- Lori Goltermann · since Jul 2, 2026
- Safwan Shabab · since Jul 2, 2026
- Thurman Justice · since Jul 2, 2026
Officers 8
- David Bourdon · Chief Executive Officer · listed since Mar 2025
- Ryan McGroarty · Chief Financial Officer and Treasurer · since Mar 17, 2025
- Lisa K Miller · Chief Operating Officer · listed since Mar 2026
- Ryan Pardo · Chief Legal Officer and Secretary · since Jun 10, 2021
- Ann Varanakis · Chief People Officer · since Feb 2, 2023
- Ujjwal Ramtekkar · Chief Medical Officer · since Jan 19, 2024
- Vukasin Paunovich · Chief Technology Officer · since Jun 9, 2025
- Stephanie Carin Eken · Chief Medical Officer · since Feb 16, 2026
10% owners 3
- James G Coulter · since Jun 10, 2021
- Jon Winkelried · since Jan 12, 2022
- Tpg Gp A, LLC (entity) · since Jan 12, 2022
Changes in the last 10 years (74)
| Jul 2, 2026 | Thurman Justice became a director |
| Jul 2, 2026 | Safwan Shabab became a director |
| Jul 2, 2026 | Lori Goltermann became a director |
| Mar 11, 2026 | Ryan Pardo first listed as a director in an SEC filing |
| Mar 11, 2026 | Lisa K Miller listed as Chief Operating Officer (previously Executive Vice President, Practice Operations) in SEC filings |
| Mar 4, 2026 | Darren M. Black no longer listed as a 10% owner in SEC filings |
| Feb 16, 2026 | Stephanie Carin Eken became Chief Medical Officer |
| Aug 20, 2025 | Summit Partners Growth Equity Fund IX-B, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 20, 2025 | Summit Partners Growth Equity Fund IX-A, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 20, 2025 | Summit Partners Entrepreneur Advisors Fund II, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 20, 2025 | Summit Investors Ge Ix/vc IV, LLC reported in an SEC filing no longer being a 10% owner |
| Aug 20, 2025 | Summit Investors Ge Ix/vc IV (uk), L.p. reported in an SEC filing no longer being a 10% owner |
| Aug 20, 2025 | Sarah Personette became a director |
| Aug 19, 2025 | The company announced the departure of William Joseph Miller from the board in an SEC filing |
| Jun 9, 2025 | Vukasin Paunovich became Chief Technology Officer |
| Jun 3, 2025 | Eric P Palmer became a director |
| May 14, 2025 | The company announced the departure of Pablo Pantaleoni as Chief Digital Officer in an SEC filing |
| Mar 17, 2025 | Ryan McGroarty became Chief Financial Officer and Treasurer |
| Mar 10, 2025 | David Bourdon listed as Chief Executive Officer (previously Chief Financial Officer) in SEC filings |
| Mar 10, 2025 | David Bourdon first listed as a director in an SEC filing |
| Feb 25, 2025 | The company announced the departure of Kenneth A Burdick as Chief Executive Officer in an SEC filing |
| Sep 24, 2024 | Lisa K Miller became Executive Vice President, Practice Operations |
| May 6, 2024 | The company announced the departure of Danish J. Qureshi as President and Chief Operating Officer in an SEC filing |
| Mar 12, 2024 | Teresa DeLuca became a director |
| Jan 19, 2024 | Ujjwal Ramtekkar became Chief Medical Officer |
| Sep 22, 2023 | Paula Cipollone became Business Transformation Officer |
| Feb 2, 2023 | Ann Varanakis became Chief People Officer |
| Nov 10, 2022 | David Bourdon became Chief Financial Officer |
| Nov 2, 2022 | The company announced the departure of Jesse Michael Bruff as Chief Financial Officer in an SEC filing |
| Sep 9, 2022 | Danish J. Qureshi listed as President and Chief Operating Officer (previously Chief Growth Officer) in SEC filings |
| Sep 7, 2022 | The company announced the departure of Michael K. Lester from the board in an SEC filing |
| Sep 7, 2022 | The company announced the departure of Michael K. Lester as President and CEO in an SEC filing |
| Sep 7, 2022 | Kenneth A Burdick became a director |
| Sep 7, 2022 | Kenneth A Burdick became Chief Executive Officer |
| Jan 12, 2022 | Tpg Gp A, LLC became a 10% owner |
| Jan 12, 2022 | Jon Winkelried became a 10% owner |
| Aug 22, 2021 | Seema Verma became a director |
| Jun 29, 2021 | Silversmith Partners I GP, LLC no longer listed as a 10% owner in SEC filings |
| Jun 29, 2021 | Silversmith Partners I GP, L.P. no longer listed as a 10% owner in SEC filings |
| Jun 29, 2021 | Silversmith Capital Partners I-C, L.P. no longer listed as a 10% owner in SEC filings |
| Jun 29, 2021 | Silversmith Capital Partners I-B, L.P. no longer listed as a 10% owner in SEC filings |
| Jun 29, 2021 | Silversmith Capital Partners I-A, L.P. no longer listed as a 10% owner in SEC filings |
| Jun 10, 2021 | William Joseph Miller became a director |
| Jun 10, 2021 | Warren Gouk became Chief Administrative Officer |
| Jun 10, 2021 | TPG Group Holdings (SBS) Advisors, Inc. became a 10% owner |
| Jun 10, 2021 | Summit Partners Growth Equity Fund IX-B, L.P. became a 10% owner |
| Jun 10, 2021 | Summit Partners Growth Equity Fund IX-A, L.P. became a 10% owner |
| Jun 10, 2021 | Summit Partners Entrepreneur Advisors Fund II, L.P. became a 10% owner |
| Jun 10, 2021 | Summit Investors Ge Ix/vc IV, LLC became a 10% owner |
| Jun 10, 2021 | Summit Investors Ge Ix/vc IV (uk), L.p. became a 10% owner |
| Jun 10, 2021 | Silversmith Partners I GP, LLC became a 10% owner |
| Jun 10, 2021 | Silversmith Partners I GP, L.P. became a 10% owner |
| Jun 10, 2021 | Silversmith Capital Partners I-C, L.P. became a 10% owner |
| Jun 10, 2021 | Silversmith Capital Partners I-B, L.P. became a 10% owner |
| Jun 10, 2021 | Silversmith Capital Partners I-A, L.P. became a 10% owner |
| Jun 10, 2021 | Ryan Pardo became Chief Legal Officer and Secretary |
| Jun 10, 2021 | Robert Bessler became a director |
| Jun 10, 2021 | Pablo Pantaleoni became Chief Digital Officer |
| Jun 10, 2021 | Michael K. Lester became a director |
| Jun 10, 2021 | Michael K. Lester became President and CEO |
| Jun 10, 2021 | Kevin Michael Mullins became Chief Development Officer |
| Jun 10, 2021 | Katherine Wood became a director |
| Jun 10, 2021 | Jesse Michael Bruff became Chief Financial Officer |
| Jun 10, 2021 | Jeffrey K. Rhodes became a director |
| Jun 10, 2021 | Jeffrey Crisan became a director |
| Jun 10, 2021 | James G Coulter became a 10% owner |
| Jun 10, 2021 | Gwen H. Booth became Chief Operating Officer |
| Jun 10, 2021 | Felicia Gorcyca became Chief People Officer |
| Jun 10, 2021 | Eric Shuey became a director |
| Jun 10, 2021 | David Bonderman became a 10% owner |
| Jun 10, 2021 | Darren M. Black became a director |
| Jun 10, 2021 | Darren M. Black became a 10% owner |
| Jun 10, 2021 | Danish J. Qureshi became Chief Growth Officer |
| Jun 10, 2021 | Anisha Patel-Dunn became Chief Medical Officer |
- Prev
- 1
Not reported recently (11)
- Seema Verma · Last reported as a director in an SEC filing dated Aug 27, 2024
- Kevin Michael Mullins · Last reported as Chief Development Officer in an SEC filing dated Jun 13, 2024
- Jeffrey K. Rhodes · Last reported as a director in an SEC filing dated Jun 3, 2024
- Jeffrey Crisan · Last reported as a director in an SEC filing dated May 29, 2024
- David Bonderman · Last reported as a 10% owner in an SEC filing dated May 29, 2024
- Paula Cipollone · Last reported as Business Transformation Officer in an SEC filing dated May 14, 2024
- Warren Gouk · Last reported as Chief Administrative Officer in an SEC filing dated Sep 5, 2023
- Anisha Patel-Dunn · Last reported as Chief Medical Officer in an SEC filing dated Jun 29, 2023
- Felicia Gorcyca · Last reported as Chief People Officer in an SEC filing dated Jun 14, 2022
- Gwen H. Booth · Last reported as Chief Operating Officer in an SEC filing dated Jun 14, 2022
- TPG Group Holdings (SBS) Advisors, Inc. · Last reported as a 10% owner in an SEC filing dated Jun 29, 2021
LFST Proposed Insider Sales (Form 144)
Latest: 2026-08-14What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | DeLuca Teresa | Director | 7,500 | $95.1K | 2026-08-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-13 | DeLuca Teresa | Director | 20,441 | $250.0K | 2026-08-13 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-11 | Burdick Kenneth A | Director | 500,000 | $5.76M | 2026-08-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-10 | TPG VIII Lynnwood Holdings Aggregation, L.P. | Stockholder | 13,643,207 | $147.89M | 2026-08-10 | Citadel Securities, LLC | — | EDGAR |
| 2026-08-10 | Miller Lisa K | Officer | 47,912 | $519.8K | 2026-08-10 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-08-10 | Paunovich Vukasin | Officer | 44,394 | $481.7K | 2026-08-10 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-08-10 | Summit Investors GE IX/VC IV (UK), L.P. | Owner | 1,273 | $13.5K | 2026-08-10 | Citadel Securities LLC | — | EDGAR |
| 2026-08-10 | Summit Partners Entrepreneur Advisors Fund II, L.P. | Owner | 1,626 | $17.3K | 2026-08-10 | Citadel Securities LLC | — | EDGAR |
| 2026-08-10 | Summit Investors GE IX-VC IV, LLC | Owner | 12,165 | $129.2K | 2026-08-10 | Citadel Securities LLC | — | EDGAR |
| 2026-08-10 | Summit Partners Growth Equity Fund IX-B, L.P. | Owner | 1,088,162 | $11.56M | 2026-08-10 | Citadel Securities LLC | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.20% | $207.9M | $104.0B | 2026-10-23 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $94.7M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.11% | $81.1M | $74.6B | 2026-10-23 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.04% | $66.9M | — | 2026-09-30 |
| 5 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.08% | $37.3M | — | 2026-09-30 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.04% | $36.6M | — | 2026-09-30 |
| 7 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.10% | $34.9M | — | 2026-10-23 |
| 8 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.20% | $31.9M | $15.8B | 2026-10-23 |
| 9 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.22% | $30.1M | $13.7B | 2026-10-23 |
| 10 | XSMO Invesco S&P SmallCap Momentum ETF | Invesco | 1.01% | $27.7M | — | 2026-10-24 |
| 11 | IJT iShares S&P Small-Cap 600 Growth ETF | iShares (BlackRock) | 0.24% | $18.1M | $7.6B | 2026-10-23 |
| 12 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.10% | $17.5M | — | 2026-09-30 |
| 13 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.02% | $16.4M | — | 2026-10-23 |
| 14 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.19% | $14.0M | — | 2026-10-23 |
| 15 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.04% | $13.9M | — | 2026-10-23 |
| 16 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.17% | $12.7M | $7.7B | 2026-10-23 |
| 17 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.19% | $11.5M | — | 2026-09-30 |
| 18 | SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF | SPDR (State Street) | 0.24% | $11.1M | $4.6B | 2026-10-23 |
| 19 | VHT Vanguard Health Care ETF | Vanguard | 0.04% | $8.4M | — | 2026-09-30 |
| 20 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.04% | $8.3M | — | 2026-05-31 |
| 21 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.17% | $8.0M | $4.8B | 2026-10-23 |
| 22 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.42% | $5.9M | $1.4B | 2026-10-23 |
| 23 | FNX First Trust Mid Cap Core AlphaDEX® Fund | First Trust | 0.39% | $5.3M | $1.4B | 2026-10-23 |
| 24 | FNY First Trust Mid Cap Growth AlphaDEX® Fund | First Trust | 0.81% | $4.4M | $542.0M | 2026-10-23 |
| 25 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $4.2M | $96.5B | 2026-10-23 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $435.35M | $23.61M | $0.06 | $99.91M |
| Q1 '26 | 2026-03-31 | $403.48M | $14.24M | $0.04 | $33.11M |
| Q4 '25 | 2025-12-31 | $382.19M | $11.67M | $0.03 | $57.56M |
| Q3 '25 | 2025-09-30 | $363.81M | $1.08M | — | $27.29M |
| Q2 '25 | 2025-06-30 | $345.31M | $-3.79M | $-0.01 | $64.40M |
| Q1 '25 | 2025-03-31 | $332.97M | $709.00K | — | $-3.09M |
| Q4 '24 | 2024-12-31 | $325.48M | $-7.11M | $-0.02 | $62.32M |
| Q3 '24 | 2024-09-30 | $312.72M | $-5.96M | $-0.02 | $22.72M |
| Q2 '24 | 2024-06-30 | $312.33M | $-23.28M | $-0.06 | $44.06M |
| Q1 '24 | 2024-03-31 | $300.44M | $-21.10M | $-0.06 | $-21.84M |
| Q4 '23 | 2023-12-31 | $280.60M | $-44.96M | $-0.12 | $16.80M |
| Q3 '23 | 2023-09-30 | $262.89M | $-61.58M | $-0.17 | $-25.36M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.